June 29, 2026
2 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
CHICAGO — In this video, Elizabeth S. McDonald, MD, discusses a retrospective, time-dependent cohort study evaluating GLP-1 receptor agonist use and breast cancer risk among women eligible for breast cancer screening.Results were presented at ASCO Annual Meeting.
June 29, 2026
2 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

GLP-1 receptor agonists may help improve outcomes among women with breast cancer and chronic cardiometabolic diseases, results of…

CHICAGO — In this video, Sherry Shen, MD, discusses her educational session on lifestyle and survivorship for patients with…

CHICAGO — GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to…

Use of drugs for overweight/obesity linked to lower risk of breast cancer, several leukemias

Accumulating evidence of possible benefit warrants randomized trials, experts say

A new study of more than 111,000 women ages 45 to 80 found those on GLP-1 medications had a reduced risk of developing breast…